Clinical Trial Update: The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

A Phase 2 study assessing safety, preliminary pharmacodynamics and pharmacokinetics of rExenatide-4 in Chinese patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• rExenatide-4

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Type 2 Diabetes | Phase 2 | Status: UNKNOWN